Moderna scales back vaccine ambitions as COVID shot revenue plunges

Moderna is dialing back its plans for new vaccines, shelving several key projects as it grapples with a sharp slowdown in COVID shot sales.

SOURCE: https://www.axios.com/2024/09/12/moderna-covid-vaccines-rsv-flu